Department of Medicine
-
November 18, 2020
Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer
Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. -
November 18, 2020
Collaborative Vanderbilt Lung Institute launches
-
November 18, 2020
New drug for metastatic colorectal cancer enters phase 3 trial
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center. -
November 17, 2020
Statins to be studied for prevention of dementia, disability and heart disease
Vanderbilt University Medical Center researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease. -
November 12, 2020
New therapeutic target for lung cancer
Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer. -
November 12, 2020
Breast cancer treatment in older women
A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women. -
November 10, 2020
Study underscores importance of personalized medicine in kidney cancer
A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions.